Classical cyclophosphamide, methotrexate, and fluorouracil chemotherapy is more effective in triple-negative, node-negative breast cancer: Results from two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer

Marco Colleoni, Bernard F. Cole, Giuseppe Viale, Meredith M. Regan, Karen N. Price, Eugenio Maiorano, Mauro G. Mastropasqua, Diana Crivellari, Richard D. Gelber, Aron Goldhirsch, Alan S. Coates, Barry A. Gusterson

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Classical cyclophosphamide, methotrexate, and fluorouracil chemotherapy is more effective in triple-negative, node-negative breast cancer: Results from two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences